Enfusion shares were trading higher after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY21 sales guidance above analyst estimates.
by | Dec 3, 2021 | Extra Jobs | 0 comments
by | Dec 3, 2021 | Extra Jobs | 0 comments
Recent Comments